Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Phase 2 Completed
68 enrolled 13 charts
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Phase 2 Completed
62 enrolled 15 charts
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
Phase 2 Completed
29 enrolled 15 charts
To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)
Phase 2 Completed
4 enrolled 10 charts
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
Phase 2 Completed
31 enrolled 8 charts
Pegasys® in Patients With Myeloproliferative Diseases
Phase 2 Completed
83 enrolled 12 charts
MOSAICC
Completed
234 enrolled 7 charts
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
Phase 2 Completed
50 enrolled 11 charts
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Phase 2 Completed
117 enrolled 27 charts
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
Phase 2 Completed
125 enrolled 38 charts
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Phase 2/3 Completed
361 enrolled 16 charts
RESPONSE-2
Phase 3 Completed
149 enrolled 19 charts
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Phase 2 Completed
10 enrolled 7 charts
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Phase 1/2 Completed
50 enrolled 23 charts
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
Phase 2 Completed
77 enrolled 16 charts
CC-4047 in Treating Patients With Myelofibrosis
Phase 1/2 Completed
77 enrolled 9 charts
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
Phase 2 Completed
29 enrolled 8 charts
PV
Phase 2 Completed
45 enrolled 10 charts
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Phase 2 Completed
94 enrolled 11 charts
A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera
Phase 1/2 Completed
48 enrolled 28 charts
Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.
Phase 3 Completed
161 enrolled 14 charts
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Phase 2 Completed
25 enrolled 8 charts
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
Phase 2 Completed
63 enrolled 9 charts
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
Phase 3 Completed
222 enrolled 21 charts
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Phase NA Completed
100 enrolled 10 charts
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Phase NA Completed
66 enrolled 9 charts
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Phase 1/2 Completed
154 enrolled 26 charts
Bu Flu TBI
Phase 1/2 Completed
147 enrolled 19 charts
LCCC0510
Phase 1/2 Completed
54 enrolled 17 charts
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Phase NA Completed
5 enrolled 6 charts
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase 3 Completed
364 enrolled 29 charts
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Phase 2 Completed
204 enrolled 7 charts
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Phase 2 Completed
210 enrolled 10 charts
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
Phase 2 Completed
35 enrolled 8 charts
Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
Phase 2 Completed
48 enrolled 7 charts
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
Phase 3 Completed
98 enrolled 14 charts